State Street’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.14M Sell
5,754,583
-625,009
-10% -$775K ﹤0.01% 2788
2025
Q1
$7.53M Sell
6,379,592
-47,383
-0.7% -$55.9K ﹤0.01% 2696
2024
Q4
$11.8M Buy
6,426,975
+150,819
+2% +$276K ﹤0.01% 2535
2024
Q3
$10.7M Buy
6,276,156
+340,766
+6% +$579K ﹤0.01% 2560
2024
Q2
$8.13M Buy
5,935,390
+166,503
+3% +$228K ﹤0.01% 2684
2024
Q1
$21.6M Buy
5,768,887
+144,558
+3% +$542K ﹤0.01% 2160
2023
Q4
$55.2M Buy
5,624,329
+252,447
+5% +$2.48M ﹤0.01% 1654
2023
Q3
$44.9M Buy
5,371,882
+43,231
+0.8% +$361K ﹤0.01% 1696
2023
Q2
$70.9M Sell
5,328,651
-34,168
-0.6% -$454K ﹤0.01% 1451
2023
Q1
$62.1M Buy
5,362,819
+135,323
+3% +$1.57M ﹤0.01% 1500
2022
Q4
$42.8M Buy
5,227,496
+176,143
+3% +$1.44M ﹤0.01% 1745
2022
Q3
$29.3M Buy
5,051,353
+710,784
+16% +$4.13M ﹤0.01% 1953
2022
Q2
$19.2M Sell
4,340,569
-88,396
-2% -$391K ﹤0.01% 2280
2022
Q1
$40.3M Buy
4,428,965
+271,315
+7% +$2.47M ﹤0.01% 1897
2021
Q4
$85.1M Sell
4,157,650
-112,957
-3% -$2.31M ﹤0.01% 1431
2021
Q3
$109M Buy
4,270,607
+17,032
+0.4% +$435K 0.01% 1187
2021
Q2
$149M Buy
4,253,575
+222,602
+6% +$7.78M 0.01% 1026
2021
Q1
$134M Buy
4,030,973
+6,283
+0.2% +$209K 0.01% 1015
2020
Q4
$104M Sell
4,024,690
-308,296
-7% -$8M 0.01% 1117
2020
Q3
$42.8M Buy
4,332,986
+91,157
+2% +$900K ﹤0.01% 1575
2020
Q2
$14.6M Buy
4,241,829
+659,610
+18% +$2.28M ﹤0.01% 2204
2020
Q1
$11M Buy
3,582,219
+340,259
+10% +$1.04M ﹤0.01% 2230
2019
Q4
$16.7M Buy
3,241,960
+259,950
+9% +$1.34M ﹤0.01% 2266
2019
Q3
$15.4M Buy
2,982,010
+72,788
+3% +$376K ﹤0.01% 2224
2019
Q2
$17.6M Buy
2,909,222
+150,186
+5% +$909K ﹤0.01% 2199
2019
Q1
$19.9M Buy
2,759,036
+156,705
+6% +$1.13M ﹤0.01% 2041
2018
Q4
$19.3M Buy
2,602,331
+219,621
+9% +$1.63M ﹤0.01% 2004
2018
Q3
$12.9M Buy
2,382,710
+135,369
+6% +$732K ﹤0.01% 2440
2018
Q2
$7.98M Buy
2,247,341
+354,804
+19% +$1.26M ﹤0.01% 2644
2018
Q1
$3.88M Buy
1,892,537
+84,603
+5% +$174K ﹤0.01% 2915
2017
Q4
$4.77M Buy
1,807,934
+169,788
+10% +$448K ﹤0.01% 2816
2017
Q3
$8.6M Buy
1,638,146
+116,901
+8% +$614K ﹤0.01% 2513
2017
Q2
$5.42M Buy
1,521,245
+106,607
+8% +$380K ﹤0.01% 2693
2017
Q1
$7.32M Buy
1,414,638
+28,504
+2% +$147K ﹤0.01% 2518
2016
Q4
$5.27M Buy
1,386,134
+68,226
+5% +$259K ﹤0.01% 2668
2016
Q3
$11.8M Sell
1,317,908
-681
-0.1% -$6.1K ﹤0.01% 2097
2016
Q2
$9.28M Buy
1,318,589
+245,925
+23% +$1.73M ﹤0.01% 2267
2016
Q1
$9.12M Buy
1,072,664
+135,746
+14% +$1.15M ﹤0.01% 2229
2015
Q4
$12.3M Buy
936,918
+115,597
+14% +$1.52M ﹤0.01% 2069
2015
Q3
$3.01M Buy
821,321
+16,504
+2% +$60.4K ﹤0.01% 2801
2015
Q2
$4.64M Buy
804,817
+807
+0.1% +$4.65K ﹤0.01% 2658
2015
Q1
$4.69M Buy
804,010
+28,941
+4% +$169K ﹤0.01% 2589
2014
Q4
$6.08M Sell
775,069
-9,610
-1% -$75.3K ﹤0.01% 2474
2014
Q3
$3.86M Buy
784,679
+62,213
+9% +$306K ﹤0.01% 2676
2014
Q2
$4.47M Buy
722,466
+41,661
+6% +$257K ﹤0.01% 2658
2014
Q1
$3.65M Buy
680,805
+45,260
+7% +$242K ﹤0.01% 2757
2013
Q4
$3.33M Buy
635,545
+89,710
+16% +$469K ﹤0.01% 2810
2013
Q3
$3.02M Buy
545,835
+5,546
+1% +$30.7K ﹤0.01% 2832
2013
Q2
$1.36M Buy
+540,289
New +$1.36M ﹤0.01% 3123